Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Diagnostic Criteria for Axial Spondylarthritis

Ann Kepler  |  Issue: February 2012  |  February 3, 2012

Exercise, including physical therapy, improves function and decreases pain. Dr. Khan recommended swimming as the best exercise for SpA patients. The exercise should not be short-term but rather the beginning of a lifelong exercise program, which is necessary in the management of a chronic condition.

ASAS recommendations on managing SpA suggest using anti-TNF agents in patients with SpA, but only after:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • A regimen of NSAIDs (at least two different drugs tried for one month or more total);
  • An adequate therapeutic trial of a disease-modifying antirheumatic drug (DMARD), preferably sulfasalazine, for patients with peripheral symptoms; and
  • An efficacy evaluation of the above steps after 12 weeks.6

Note that patients with axial spondylarthritis do not need to take a DMARD before or concomitant with an anti-TNF agent.

All TNF inhibitors are remarkably effective as monotherapy for treating SpA, and the response is even better in early disease. TNF inhibitors have long-term efficacy and an acceptable safety profile, but there is a need for adequate intake of vitamin D and calcium and for ongoing screening for concomitant osteopenia and osteoporosis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

 


Ann Kepler is a medical journalist based in Chicago.

References

  1. Grigg SE, Martin BJ, Buchanan RR, Schachna L. Burden of delay to diagnosis of ankylosing spondylitis. [abstract]. Arthritis Rheum. 2011;63(Suppl 10):1308.
  2. Brown MA. The evolving roles of genes and gene expression profiling in ankylosing spondylitis. Ann Rheum Dis. 2011;70(Suppl 3);7.
  3. Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68:784-788.
  4. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63:535-543.
  5. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68:777-783.
  6. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl II):ii1–ii44.

Page: 1 2 3 | Single Page
Share: 

Filed under:Axial SpondyloarthritisClinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual MeetingAnkylosing Spondylitisanti-inflammatoryaxial spondyloarthritis (SpA)Diagnostic CriteriaimagingPainpatient careReactive arthritisSafety

Related Articles

    “A Common Language for Spondyloarthritis”

    December 1, 2010

    ASAS fills a niche, changes dogma with consensus approach

    The Classification Challenge of Pediatric Spondylarthritis

    April 1, 2010

    Condition often confused with other disorders

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences